Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02018822 · ClinicalTrials.gov registry record · NA

Evaluate the Effectiveness of an Experimental Urethane Dimethacrylate Resin Based Dental Composite Material

A NA study, sponsored by University of Rochester.

Completed
Registry status
NA
Development phase
85
Enrollment target

NCT02018822: Completed NA study, sponsored by University of Rochester.

NCT02018822 is a NA study that has completed, run by University of Rochester. The registered enrollment target is 85 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02018822, a NA study, has completed, sponsored by University of Rochester.

COMPLETED
Registry status
NA
Development phase
85 participants
Enrollment target

Study Summary

This double blind randomized controlled prospective clinical trial will compare the clinical success of two tooth colored resin composite dental filling materials - TPH3 (Dentsply Caulk) and an experimental urethane dimethacrylate resin based composite resin (Dentsply Caulk) for wear resistance, staining and marginal seal using modified Ryge criteria to evaluate the posterior restorations for 24 months in duration

Primary Outcome

Anatomic form was graded as: A=The restoration is continuous with existing form. B=The restoration is discontinuous with existing anatomic form, but the existing material is not sufficient to expose dentine.

Interventions

  • DEVICE urethane dimethacrylate
  • DEVICE TPH3
  • DEVICE Esthet-X HD

Trial Details

FieldValue
Enrollment Target 85 participants
Start Date 2013-06
Est. Completion 2017-09
Phase NA
University of Rochester

636 total trials

What the finished NCT02018822 record still lists

NCT02018822 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 85 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).

The record links to 0 conditions, and to 3 interventions - of which urethane dimethacrylate is the first listed.

NCT02018822 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02018822 about?

NCT02018822 is a clinical study titled "Evaluate the Effectiveness of an Experimental Urethane Dimethacrylate Resin Based Dental Composite Material". This double blind randomized controlled prospective clinical trial will compare the clinical success of two tooth colored resin composite dental filling materials - TPH3 (Dentsply Caulk) and an experimental urethane dimethacrylate resin based composite resin (Dentsply Caulk) for wear resistance, sta...

What is the current status of trial NCT02018822?

This trial is currently completed. It is a NA study. The enrollment target is 85 participants. The study started on 2013-06. Estimated completion is 2017-09.

What interventions are being tested in trial NCT02018822?

The interventions under investigation include: urethane dimethacrylate (DEVICE), TPH3 (DEVICE), Esthet-X HD (DEVICE).

Who is sponsoring clinical trial NCT02018822?

This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02018822's enrollment target sits among peer trials

85 980th of 2000 higher than 1,018 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00842283 · 85 participants

    Role of Angiogenesis in Dermatologic Diseases: A Potential Therapeutic Target

  • NCT02133196 · 85 participants · Phase 2

    T Cell Receptor Immunotherapy for Patients With Metastatic Non-Small Cell Lung Cancer

  • NCT03823144 · 85 participants · NA

    Intravital Microscopy in Human Solid Tumors

  • NCT03875638 · 85 participants · Phase 2

    Treating Hyperexcitability in AD With Levetiracetam

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02018822, the US trial registry maintained by the National Library of Medicine. NCT02018822 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.